Quarterly report pursuant to Section 13 or 15(d)

STATEMENTS OF CONSOLIDATED CASH FLOWS

v3.21.1
STATEMENTS OF CONSOLIDATED CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash, Cash Equivalents and Restricted Cash:    
Beginning of period $ 5,910 $ 5,238
End of period 7,731 8,956
Net income attributable to common shareowners 4,792 965
Depreciation and amortization 722 648
Pension and postretirement benefit (income) expense (3,024) 160
Payment for Pension and Other Postretirement Benefits (215) (222)
Increase (Decrease) in Self Insurance Reserve 4 124
Deferred tax (benefit) expense 942 86
Stock compensation expense 315 231
Other Noncash Income (Expense) 57 33
Increase (Decrease) in Accounts Receivable 435 1,223
Increase (Decrease) in Other Operating Assets 363 209
Increase (Decrease) in Accounts Payable (261) (1,101)
Increase (Decrease) in Employee Related Liabilities 199 83
Increase (Decrease) in Other Operating Liabilities 180 102
Increase (Decrease) in Other Operating Assets and Liabilities, Net 22 9
Net Cash Provided by (Used in) Operating Activities 4,531 2,550
Payments to Acquire Property, Plant, and Equipment (834) (933)
Proceeds from disposals of property, plant and equipment 10 1
Payments to Acquire Investments (78) (80)
Sales and maturities of marketable securities 134 80
Payments for (Proceeds from) Loans Receivable 11 3
Cash paid for business acquisitions, net of cash and cash equivalents acquired (3) 0
Payments for (Proceeds from) Other Investing Activities (6) (5)
Net Cash Provided by (Used in) Investing Activities (766) (934)
Net change in short-term debt 697 (91)
Proceeds from long-term borrowings 0 4,253
Repayments of Long-term Debt (1,528) (687)
Payments for Repurchase of Common Stock 0 (220)
Issuances of common stock 78 70
Payments of Dividends (858) (840)
Other financing activities (334) (318)
Net Cash Provided by (Used in) Financing Activities (1,945) 2,167
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash 1 (65)
Net decrease in cash, cash equivalents and restricted cash $ 1,821 $ 3,718